Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Administration of EV71 Vaccine with MMR and Japanese Encephalitis Vaccines
NCT04111432Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jul 2019
- Primary completion
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), sponsored by Sinovac Biotech Ltd.. Started Jul 2019; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT04111432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111432.